University of California San Francisco (UCSF) Medical Center
Welcome,         Profile    Billing    Logout  
 2 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jordan, Stanley C
ConfIdeS, NCT04935177: Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx

Active, not recruiting
3
64
US
Imlifidase, IdeS, HMED-IdeS, PLEX, Plasma exchange, PE, IVIg, Intravenous immunoglobulin, Anti-CD20 antibodies, Rituximab, Eculizumab, Soliris, Remain on wait list
Hansa Biopharma AB
Kidney Transplantation in Highly Sensitized Patients
06/25
06/25
NCT03380962: Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Active, not recruiting
1/2
20
US
Clazakizumab, Anti-IL-6 monoclonal
Stanley Jordan, MD
Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy, Transplant;Failure,Kidney, Kidney Transplant Failure and Rejection, Antibody-mediated Rejection, Kidney Transplant; Complications
07/25
07/25
NCT03380377: Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

Completed
1/2
10
US
Clazakizumab
Stanley Jordan, MD
Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy, Transplant Glomerulopathy - Late Form, Transplant Glomerulopathy - Early Form, Kidney Transplant Rejection
04/24
04/24
Kim, Jim
ConfIdeS, NCT04935177: Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx

Active, not recruiting
3
64
US
Imlifidase, IdeS, HMED-IdeS, PLEX, Plasma exchange, PE, IVIg, Intravenous immunoglobulin, Anti-CD20 antibodies, Rituximab, Eculizumab, Soliris, Remain on wait list
Hansa Biopharma AB
Kidney Transplantation in Highly Sensitized Patients
06/25
06/25
Adey, D
ConfIdeS, NCT04935177: Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx

Active, not recruiting
3
64
US
Imlifidase, IdeS, HMED-IdeS, PLEX, Plasma exchange, PE, IVIg, Intravenous immunoglobulin, Anti-CD20 antibodies, Rituximab, Eculizumab, Soliris, Remain on wait list
Hansa Biopharma AB
Kidney Transplantation in Highly Sensitized Patients
06/25
06/25

Download Options